Intracerebral infusion of (+)-AJ76 and (+)-UH232:
effects on dopamine release and metabolism in vivo
Waters N, Hansson L, Lofberg L, Carlsson A
Department of Pharmacology,
University of Goteborg, Sweden.
Eur J Pharmacol 1994 Jan 14; 251(2-3):181-90
ABSTRACTThe dopamine D3- and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232 were administered locally in the striatum and the nucleus accumbens. Their effects on dialysate dopamine and 3,4-di-hydroxyphenylacetic acid (DOPAC) were measured and compared with the effects of raclopride. (+)-AJ76 and (+)-UH232 but not raclopride seem to interact primarily with dopamine receptors in the terminal regions of the A9 and A10 dopaminergic fibers to exert their maximal effect on dopamine release in vivo. Thus, (+)-AJ76 and (+)-UH232 seem to recruit different dopamine receptor populations as compared to raclopride. Though the dopamine receptor antagonist-induced effects on dopamine release seem to be mediated mainly by dopamine receptors in the terminal areas, the effects on DOPAC by the different antagonists seem to be mediated mainly via effects elsewhere, presumably at the somatodendritic autoreceptors. Thus, it is suggested that the regulation of extracellular dopamine and DOPAC after treatment with dopamine receptor antagonists are subjected to different control mechanisms.AJ 76
AJ 76 and UH 232
The coke-craving brain
AJ 76, UH 232 and dopamine
Monoamines, cocaine and rats
Freebasing flies go hyperkinetic
GBR12909: a dopaminergic antidepressant?
01 02 03 04 05 06 07 08 09 10 11 12
13 14 15 16 17 18 19 20 21 22 23 24
The Hedonistic Imperative
When Is It Best to Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide To
Healthy Mood Boosters For All The Family